Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06273748 · ClinicalTrials.gov registry record
RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age
A clinical trial of Uveitis, sponsored by Meyer Children's Hospital IRCCS.
- Recruiting
- Registry status
- 290
- Enrollment target
- 5
- Study locations
NCT06273748: Recruiting study of Uveitis, sponsored by Meyer Children's Hospital IRCCS.
NCT06273748 is a study of Uveitis that is actively recruiting participants, run by Meyer Children's Hospital IRCCS. The registered enrollment target is 290 participants, below the 602-participant average among 19 other Uveitis trials with a reported enrollment target (52% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06273748, a study of Uveitis, is actively recruiting participants, sponsored by Meyer Children's Hospital IRCCS.
- RECRUITING
- Registry status
- 290 participants
- Enrollment target
- 5
- Study locations
Study Summary
Uveitis is an inflammatory disease of the uvea, one of the highly vascularized fundamental structures of the eye. It is a rare condition in children, with an incidence in the pediatric population ranging from 2% to 14% of all uveitis cases. The diagnosis and management of patients with uveitis rely on a multidisciplinary approach involving an ophthalmologist, a rheumatologist, and an infectious disease specialist to establish the correct diagnosis and assess the involvement of other organs. In Italy, there is no national or regional registry for non-infectious chronic uveitis as per the Prime Ministerial Decree (DPCM) of March 3, 2017 (Identification of surveillance systems and registries for mortality, tumors, and other diseases). However, many clinical centers adopt data recording systems to evaluate the quality of care and to study diseases and outcomes. The Universitary Hospital Meyer Institute Research Hospital (IRCCS) is a national referral center for managing these pediatric cases of non-infectious chronic uveitis, estimated to constitute 95% of all pediatric uveitis cases
Primary Outcome
* Frequency of each aetiology of uveitis * Frequency of signs and symptoms at onset of uveitis * Frequency of laboratory findings * Frequency of each anatomical subtype of uveitis
Conditions Studied
Study Locations (5)
Other
- - ATTIKON General Hospital - Athens
- Ospedale Spedali Civili di Brescia - Brescia
- IRCCS materno infantile Burlo Garofolo - Trieste
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Firenze
- Meyer Children's Hospital IRCCS - Florence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2032-05-02 |
What NCT06273748 shows while recruiting
NCT06273748 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap, below the 602-participant average among 19 other Uveitis trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Uveitis appearing as the primary indexed condition, and to 0 interventions.
NCT06273748 lists 5 locations in 3 states (Other, Ohio, Firenze).
Frequently Asked Questions
What is clinical trial NCT06273748 about?
NCT06273748 is a clinical study titled "RChildUV:Study on Non-infectious Chronic Uveitis in Pediatric Age". Uveitis is an inflammatory disease of the uvea, one of the highly vascularized fundamental structures of the eye. It is a rare condition in children, with an incidence in the pediatric population ranging from 2% to 14% of all uveitis cases. The diagnosis and management of patients with uveitis rely ...
What is the current status of trial NCT06273748?
This trial is currently recruiting. The enrollment target is 290 participants. The study started on 2022-02-10. Estimated completion is 2032-05-02.
What conditions does trial NCT06273748 study?
This clinical trial studies the following conditions: Uveitis.
Who is sponsoring clinical trial NCT06273748?
This trial is sponsored by Meyer Children's Hospital IRCCS, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06273748 being conducted?
This trial has 5 study locations across Ohio, Firenze. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06273748's enrollment target sits among peer trials
290 6th of 19 higher than 14 of 19 other Uveitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uveitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetics of Uveitis
RECRUITING
-
Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography
RECRUITING
-
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
RECRUITING · NA
-
The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment
RECRUITING · Phase 3
-
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
RECRUITING · Phase 1
-
Imaging Quantification of Inflammation (IQI)
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI